Covered recipient · General Payments record
FRANK SPENDAL
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2020
$893.46
- Reported across 25 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2020 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $308.72 | 11 |
By paying entity
PY2020 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $178.93 | 3 |
| GlaxoSmithKline, LLC. | $43.08 | 3 |
| Allergan Inc. | $23.44 | 1 |
| Ultragenyx Pharmaceutical Inc. | $22.37 | 1 |
| ABBVIE INC. | $16.00 | 1 |
| Lilly USA, LLC | $12.55 | 1 |
| Supernus Pharmaceuticals, Inc. | $12.35 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2020 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $16.00 | 09/08/2020 | Food and Beverage | Undisputed | 01/23/2026 | 722138883 | CMS |
| Allergan, Inc. | $23.44 | 04/14/2020 | Food and Beverage | Undisputed | 01/23/2026 | 723621835 | CMS |
| GlaxoSmithKline, LLC. | $14.04 | 05/13/2020 | Food and Beverage | Undisputed | 01/23/2026 | 738852389 | CMS |
| GlaxoSmithKline, LLC. | $17.37 | 06/16/2020 | Food and Beverage | Undisputed | 01/23/2026 | 738725413 | CMS |
| GlaxoSmithKline, LLC. | $11.67 | 09/30/2020 | Food and Beverage | Undisputed | 01/23/2026 | 738756681 | CMS |
| Lilly USA, LLC | $12.55 | 11/06/2020 | Food and Beverage | Undisputed | 01/23/2026 | 728437495 | CMS |
| PFIZER INC. | $124.74 | 03/10/2020 | Food and Beverage | Undisputed | 01/23/2026 | 743367739 | CMS |
| PFIZER INC. | $25.38 | 08/07/2020 | Food and Beverage | Undisputed | 01/23/2026 | 743441898 | CMS |
| PFIZER INC. | $28.81 | 11/23/2020 | Food and Beverage | Undisputed | 01/23/2026 | 743584627 | CMS |
| Supernus Pharmaceuticals, Inc. | $12.35 | 10/16/2020 | Food and Beverage | Undisputed | 01/23/2026 | 748364937 | CMS |
| Ultragenyx Pharmaceutical Inc. | $22.37 | 12/22/2020 | Food and Beverage | Undisputed | 01/23/2026 | 723163975 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020
- Generated from
- OP_DTL_GNRL_PGYR2020_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.